Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
10 Hints and Deceives to Expand Cell Phone Information Use: Capitalize on Your Information - 2Trouvez La Carte De Cr\u00e9dit Id\u00e9ale Pour Vos Besoins En Belgique
- 3Blood pressure drug recalled for possible cross-contamination
- 4This Luxurious Thermal Spa In Italy Is Perfect For A Relaxing Escape While Visiting Milan
- 5Israeli naval intelligence reduces Iranian threat to Strait of Hormuz
- Who is Adm. Frank 'Mitch' Bradley and what does he have to do with the Venezuela boat strikes?
- Excelling at Discussion: Genuine Examples of overcoming adversity
- NASA releases stunning new images captured by the Artemis II moon mission, including 'Earthset' and a solar eclipse from space
- Heart disease risk greater for women with a common condition they may not be aware they have
- Dozens killed as Angola flood death toll rises
- Why Tourists May Want To Reconsider Traveling To This Popular Spot In Italy In 2026
- Dick Van Dyke shares his secrets to longevity as he turns 100
- Which European countries have mandatory or voluntary military service
- Pentagon advances Golden Dome missile defense with new Space Force contracts
